Histone Therapeutics

About Histone Therapeutics

Histone Therapeutics specializes in precision epigenetic reprogramming to enhance cell function by utilizing protein modifiers that regulate chromatin remodeling. The company aims to provide targeted therapeutic options for diseases linked to gene regulation dysfunction.

What does Histone Therapeutics do?

Histone Therapeutics specializes in precision epigenetic reprogramming to enhance cell function by utilizing protein modifiers that regulate chromatin remodeling. The company aims to provide targeted therapeutic options for diseases linked to gene regulation dysfunction.

Where is Histone Therapeutics located?

Histone Therapeutics is based in Victoria, Hong Kong.

When was Histone Therapeutics founded?

Histone Therapeutics was founded in 2023.

Who founded Histone Therapeutics?

Histone Therapeutics was founded by Shiri Levy.

  • Shiri Levy - Founder/CSO
Location
Victoria, Hong Kong
Founded
2023
Employees
7 employees
Looking for specific startups?
Try our free semantic startup search

Histone Therapeutics

Score: 79/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Histone Therapeutics specializes in precision epigenetic reprogramming to enhance cell function by utilizing protein modifiers that regulate chromatin remodeling. The company aims to provide targeted therapeutic options for diseases linked to gene regulation dysfunction.

histonetx.com500+
Founded 2023 – Victoria, Hong Kong

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Shiri Levy

Founder/CSO

Histone Therapeutics | StartupSeeker